- Animal Sciences
- Basel team
- Benelux team
- Biometrics team
- Boston team
- Brussels team
- Business Support team
- Cardiff team
- Client Services team
- Clinical team
- Contract team
- Contractor Care team
- CRO Delivery
- Executive Board of Directors
- Frankfurt team
- FSP team
- HEOR & Commercial team
- Internal Recruitment
- IT & Digital Transformation Team
- London Staffing Team
- London team
- Los Angeles team
- Medical Affairs team
- Medical Communications team
- Medical Devices & MedTech team
- Melbourne team
- Miami team
- MSP delivery team
- Munich team
- New York team
- North America team
- Pharmacovigilance team
- Philadelphia team
- 黑料视频 Engage team
- 黑料视频 Executive team
- Professional services
- QA/Compliance team
- Regulatory team
- San Diego team
- San Francisco
- Scientific team
- Spain, Italy, Portugal & France team
- Sydney team
- Tech Ops team
- Tokyo team
Mark joined Proclincal in 2022. Mark heads up the 黑料视频 Engage brand, leveraging complementary solutions from the company’s Staffing division to address the needs of life sciences companies throughout the life cycle.
With a career spanning over two decades, Mark has driven strategic workforce operations on both the consulting and sponsor sides of this industry, working in drug development for Pfizer, Abbott Labs and Roche; as well as heading life science solutions for Kelly Services, and some of the leading global CROs. As a solutions architect, he has applied strategic workforce models like FSP in combination with MSP, Staffing and RPO to yield a customized rounded programmatic resourcing strategy that meets the demands of biopharmaceutical companies.
A graduate of the University of Michigan, Mark earned degrees in Health Economics, Biology, and a Masters in Physiotherapy.
Due to a desire for continuous learning and idea sharing, Mark is a well-known speaker at many industry conferences, and has authored numerous industry articles including “Mapping the Workforce Genome”; has been quoted in the best seller “Lead the Work” and has appeared on the History Channel, where he discussed the evolution of the drug development industry.